1P-AL-LAD

Last updated
1P-AL-LAD
1P-AL-LAD structure.png
Clinical data
Other names1-Propionyl-AL-LAD
Routes of
administration
Oral
Drug class Serotonergic psychedelic; Hallucinogen
Identifiers
  • (6aR,9R)-N,N-diethyl-4-propanoyl-7-prop-2-enyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChem CID
Chemical and physical data
Formula C25H31N3O2
Molar mass 405.542 g·mol−1
3D model (JSmol)
  • CCC(=O)N1C=C2C[C@@H]3C(=C[C@H](CN3CC=C)C(=O)N(CC)CC)C4=C2C1=CC=C4
  • InChI=1S/C25H31N3O2/c1-5-12-27-15-18(25(30)26(7-3)8-4)13-20-19-10-9-11-21-24(19)17(14-22(20)27)16-28(21)23(29)6-2/h5,9-11,13,16,18,22H,1,6-8,12,14-15H2,2-4H3/t18-,22-/m1/s1
  • Key:GAGOTJNMWJYWMB-XMSQKQJNSA-N

1P-AL-LAD, also known as 1-propionyl-AL-LAD, is a derivative of lysergic acid diethylamide (LSD) which has psychedelic effects and has been sold as a designer drug. It is believed to act as a prodrug for AL-LAD and produces a head-twitch response in animal studies. [1]

Contents

Use and effects

Interactions

Chemistry

Analogues

Analogues of 1P-AL-LAD include AL-LAD, 1cP-AL-LAD, 1T-AL-LAD, 1P-ETH-LAD, and 1P-LSD, among others.

See also

References

  1. Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Whitelock K, Stratford A, Auwärter V, Halberstadt AL (August 2022). "Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD". Drug Testing and Analysis. 14 (8): 1503–1518. doi:10.1002/dta.3281. PMC   9546273 . PMID   35524430.